Drug Information

Drug General Information
Drug ID
D00SOZ
Former ID
DIB001660
Drug Name
DE-117
Indication Glaucoma [ICD9: 365; ICD10:H40-H42] Phase 2 [524813]
Target and Pathway
Target(s) Prostaglandin E2receptor, EP2 subtype Target Info Agonist [551625]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
Inflammatory mediator regulation of TRP channels
Renin secretion
Pathways in cancer
Reactome Prostanoid ligand receptors
G alpha (s) signalling events
WikiPathways Prostaglandin Synthesis and Regulation
GPCRs, Class A Rhodopsin-like
Ovarian Infertility Genes
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 524813ClinicalTrials.gov (NCT02179008) Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension. U.S. National Institutes of Health.
Ref 551625Clinical pipeline report, company report or official report of Santen Pharmaceutical.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.